These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 22407156)

  • 1. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
    D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
    Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy.
    Bagni O; D'Arienzo M; Chiaramida P; Chiacchiararelli L; Cannas P; D'Agostini A; Cianni R; Salvatori R; Scopinaro F
    Nucl Med Commun; 2012 Feb; 33(2):198-204. PubMed ID: 22124359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
    Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
    Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study.
    Fourkal E; Veltchev I; Lin M; Koren S; Meyer J; Doss M; Yu JQ
    Med Phys; 2013 Aug; 40(8):081702. PubMed ID: 23927299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.
    Ng SC; Lee VH; Law MW; Liu RK; Ma VW; Tso WK; Leung TW
    J Appl Clin Med Phys; 2013 Sep; 14(5):212-21. PubMed ID: 24036875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
    Tapp KN; Lea WB; Johnson MS; Tann M; Fletcher JW; Hutchins GD
    J Nucl Med; 2014 Sep; 55(9):1452-8. PubMed ID: 24982437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.
    Lhommel R; van Elmbt L; Goffette P; Van den Eynde M; Jamar F; Pauwels S; Walrand S
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1654-62. PubMed ID: 20422185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Y microsphere therapy: does 90Y PET/CT imaging obviate the need for 90Y Bremsstrahlung SPECT/CT imaging?
    Zade AA; Rangarajan V; Purandare NC; Shah SA; Agrawal AR; Kulkarni SS; Shetty N
    Nucl Med Commun; 2013 Nov; 34(11):1090-6. PubMed ID: 23942324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
    D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
    Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
    Pasciak AS; Bourgeois AC; Bradley YC
    J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization.
    Seevinck PR; van de Maat GH; de Wit TC; Vente MA; Nijsen JF; Bakker CJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e437-44. PubMed ID: 22633554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (90)Y-PET/CT Imaging Quantification for Dosimetry in Peptide Receptor Radionuclide Therapy: Analysis and Corrections of the Impairing Factors.
    Fabbri C; Bartolomei M; Mattone V; Casi M; De Lauro F; Bartolini N; Gentili G; Amadori S; Agostini M; Sarti G
    Cancer Biother Radiopharm; 2015 Jun; 30(5):200-10. PubMed ID: 25860616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.
    Sarfaraz M; Kennedy AS; Lodge MA; Li XA; Wu X; Yu CX
    Med Phys; 2004 Sep; 31(9):2449-53. PubMed ID: 15487724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy.
    van Elmbt L; Vandenberghe S; Walrand S; Pauwels S; Jamar F
    Phys Med Biol; 2011 Nov; 56(21):6759-77. PubMed ID: 21970976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.